GCG and obesity disorder: Takeda G protein–coupled receptor 5 activation by secondary BAs is reported to prevent obesity and insulin resistance through energy expenditure induction in brown adipose tissue and skeletal muscles,25 as well as by stimulating GLP-1 secretion from intestinal endocrine cells.26